Cargando…

Expression levels of insulin-like growth factors and receptors in hepatocellular carcinoma: a retrospective study

BACKGROUND: The insulin-like growth factor (IGF) pathway is implicated in the pathogenesis of hepatocellular carcinoma (HCC) and may be important in nonalcoholic fatty liver disease (NAFLD). The aim of this study is to determine expression levels of IGFs and receptors in NAFLD-associated HCC. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chun, Yun Shin, Huang, Min, Rink, Lori, Von Mehren, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112617/ https://www.ncbi.nlm.nih.gov/pubmed/25052889 http://dx.doi.org/10.1186/1477-7819-12-231

Ejemplares similares

Succinate Dehydrogenase Deficiency in Pediatric and Adult Gastrointestinal Stromal Tumors
por: Belinsky, Martin G., et al.
Publicado: (2013)

ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor
por: Rink, Lori, et al.
Publicado: (2013)

Targeting insulin-like growth factor axis in hepatocellular carcinoma
por: Wu, Jennifer, et al.
Publicado: (2011)

Succinate dehydrogenase deficiency in a PDGFRA mutated GIST
por: Belinsky, Martin G., et al.
Publicado: (2017)

Increased expression of insulin-like growth factor-1 receptor predicts poor prognosis in patients with hepatocellular carcinoma
por: Zhang, Zhiquan, et al.
Publicado: (2019)

Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival
por: Wang, Fang, et al.
Publicado: (2018)

MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor
por: Xiao, Yao, et al.
Publicado: (2016)

The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma
por: Pivonello, Claudia, et al.
Publicado: (2016)

Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma
por: Akiel, Maaged, et al.
Publicado: (2014)

Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits the growth and invasion of hepatocellular carcinoma via down-regulating midkine expression
por: Bie, Cai Qun, et al.
Publicado: (2016)

Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinoma
por: Yan, Jinjin, et al.
Publicado: (2017)

Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case
por: Belinsky, Martin G., et al.
Publicado: (2015)

Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer
por: Amutha, Periyasamy, et al.
Publicado: (2017)

Expression and Significance of Insulin Receptor Substrate 1 in Human Hepatocellular Carcinoma
por: Gao, Chun, et al.
Publicado: (2020)

How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor
por: Xu, Yibin, et al.
Publicado: (2022)

MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1
por: Ye, Ying, et al.
Publicado: (2022)

Role of insulin receptor substrates in the progression of hepatocellular carcinoma
por: Sakurai, Yoshitaka, et al.
Publicado: (2017)

Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma
por: Kaseb, Ahmed O., et al.
Publicado: (2014)

Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma
por: Abdel-Wahab, Reham, et al.
Publicado: (2015)

Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway
por: Ou, Da-Liang, et al.
Publicado: (2013)

Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation
por: Tian, Dan, et al.
Publicado: (2016)

Niclosamide Revitalizes Sorafenib through Insulin-like Growth Factor 1 Receptor (IGF-1R)/Stemness and Metabolic Changes in Hepatocellular Carcinoma
por: Peng, Syue-Wei, et al.
Publicado: (2023)

Deciphering Brain Insulin Receptor and Insulin‐Like Growth Factor 1 Receptor Signalling
por: Kleinridders, A.
Publicado: (2016)

Insulin, insulin-like growth factor–1, insulin receptor, and insulin-like growth factor–1 receptor expression in the chick eye and their regulation with imposed myopic or hyperopic defocus
por: Penha, Alexandra Marcha, et al.
Publicado: (2011)

Emerging role of Toll-like receptor 4 in hepatocellular carcinoma
por: Yang, Jing, et al.
Publicado: (2015)

A Yes-Associated Protein (YAP) and Insulin-Like Growth Factor 1 Receptor (IGF-1R) Signaling Loop Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
por: Ngo, Mai-Huong T., et al.
Publicado: (2021)

Insulin-Like Growth Factor Binding Protein-2 Promotes Proliferation and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Ma, Yang, et al.
Publicado: (2020)

Serum Insulin-Like Growth Factor-1 Predicts Disease Progression and Survival in Patients with Hepatocellular Carcinoma Who Undergo Transarterial Chemoembolization
por: Cho, EunJu, et al.
Publicado: (2014)

BRCA1 regulates insulin-like growth factor 1 receptor levels in ovarian cancer
por: LIU, BO, et al.
Publicado: (2014)

Adult growth hormone deficiency treatment with a combination of growth hormone and insulin-like growth factor-1 resulting in elevated sustainable insulin-like growth factor-1 and insulin-like growth factor binding protein 3 plasma levels: a case report
por: Braverman, Eric R, et al.
Publicado: (2010)

Targeting the insulin-like growth factor-1 receptor in MTAP-deficient renal cell carcinoma
por: Xu, Jihao, et al.
Publicado: (2019)

Insulin and insulin like growth factor II endocytosis and signaling via insulin receptor B
por: Giudice, Jimena, et al.
Publicado: (2013)

Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort
por: Huber, Yvonne, et al.
Publicado: (2018)

MON-314 Insulin-like Growth Factor 2 Drives Hepatocellular Carcinoma In Hepatocyte Srsf3 Ko Mice
por: Kumar, Deepak, et al.
Publicado: (2019)

Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance
por: Galal, Mariam Ahmed, et al.
Publicado: (2023)

Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups
por: Björner, Sofie, et al.
Publicado: (2016)

Insulin-like growth factors: Ligands, binding proteins, and receptors
por: LeRoith, Derek, et al.
Publicado: (2021)

Glycan Modulation of Insulin‐like Growth Factor‐1 Receptor
por: Boothello, Rio S., et al.
Publicado: (2022)

Insulin-like growth factor-2 regulates basal retinal insulin receptor activity
por: Zolov, Sergey N., et al.
Publicado: (2021)

Effects of Zinc Status on Expression of Zinc Transporters, Redox-Related Enzymes and Insulin-like Growth Factor in Asian Sea Bass Cells
por: Sansuwan, Kanokwan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ud9vg1old807ed0efmv9vnvtfc